{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-23-000301","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.568450+00:00","generated_at":"2026-06-17T14:35:08.454640+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Lipella Pharmaceuticals appoints Daniel Cohen to Board and Audit Committee","bullets":["Board appointed Daniel Cohen as director on March 21, 2023, expanding board to seven members.","Cohen will serve until the next annual meeting and then stand for election.","He was assigned to the Board's audit committee.","No arrangements or understandings with any other persons regarding his appointment.","Entered into no transactions requiring disclosure under Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-23-000301","json":"https://secwatch.observer/filing/0001753926-23-000301.json","markdown":"https://secwatch.observer/filing/0001753926-23-000301.md","text":"https://secwatch.observer/filing/0001753926-23-000301.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392623000301/0001753926-23-000301-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392623000301/g083458_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T14:35:08.454640+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"87e09cb7b7","claim":"Daniel Cohen was appointed as Director at LIPELLA PHARMACEUTICALS INC..","evidence_excerpt":"On March 21, 2023, the board of directors (the “Board”) of Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company”), pursuant to its powers under the Company’s second amended and restated by-laws, appointed Daniel Cohen as a member of the Board, thereby increasing the Board membership count to seven (7).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1347242/000175392623000301/0001753926-23-000301-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}